SALIMAH CHAGANI: Open Payments
NPI 1437608684 · DULUTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,182 in 47 payments from 24 companies in 2025. Trend: 2023 $1,420 · 2024 $890 · 2025 $1,182
Food & beverage: $1,161Education: $20
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $237 |
| Chiesi USA, Inc. | 1 | $83 |
| Mannkind Corporation | 4 | $76 |
| BETA BIONICS, INC. | 3 | $70 |
| Tandem Diabetes Care, Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $67 |
| Ionis Pharmaceuticals, Inc. | 3 | $62 |
| Corcept Therapeutics | 2 | $59 |
| SANOFI-AVENTIS U.S. LLC | 2 | $48 |
| Abbott Laboratories | 2 | $43 |
Products named: EVENITY, MYCAPSSA, AFREZZA, iLet Bionic Pancreas, t:slim X2 Insulin Pump with Control-IQ, TRYNGOLZA, Korlym, TEPEZZA.
Industry payments across GA — which companies pay providers there.
